Top

Published in:

01-03-2015 | Original Article

Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients

Authors: F. Selvaggi, C. Fucini, G. Pellino, G. Sciaudone, I. Maretto, I. Mondi, N. Bartolini, F. Caminati, S. Pucciarelli

Published in: Techniques in Coloproctology | Issue 3/2015

Abstract

Background

Surgery is the only curative treatment in patients with locally recurrent rectal cancer (LRRC). The aim of this study was to evaluate the outcome and the prognostic factors of tumour-free resection margin (R0) and overall survival (OS) in LRRC.

Methods

Consecutive LRRC patients observed between 1987 and 2005 in three Italian university hospitals were evaluated. Survival curves were estimated using the Kaplan–Meier method and compared with the log-rank test. In order to identify factors associated with both R0 resection and OS, a logistic regression analysis was performed in patients who underwent surgery with curative intent.

Results

Out of 150 patients with LRRC, 107 underwent surgery, but since 7 were found to have unresectable disease only 100 underwent surgical resection. Of them, 51 underwent radical and 49 extended resection. Sixty of the 107 patients underwent multimodality treatment. In 61 patients, R0 resection was achieved. Median OS after surgery was 43.4 months. In patients, who had surgery with curative intent, independent variables associated with R0 resection were: surgery for the primary tumour performed in other hospitals (p = 0.042) extended resection (p = 0.025) and use of positron emission tomography (PET) as a staging modality (p = 0.03). Independent variables associated with OS were: post-operative radiotherapy (p = 0.004), stage of the primary tumour (p = 0.004), R0 resection (p = 0.00001), and use of PET (0.02).

Conclusions

Resection for LRRC results in improved survival. Other than the well-known prognostic factors R0 resection and OS, PET scan has an independent impact both on OS and R0 resection. It should therefore be included in routine clinical practice when staging LRRC.

Heriot A, Kumar D (2000) Rectal cancer recurrence: factors and mechanisms. Colorectal Dis 2:126–137CrossRefPubMed

Ito K, Ohtsu A, Ishikura S et al (2003) Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer. Jpn J Clin Oncol 33:180–185CrossRefPubMed

Sagar PM, Pemberton JH (1996) Surgical management of locally recurrent rectal cancer. Br J Surg 83:293–304CrossRefPubMed

Moriya Y, Akasu T, Fujita S, Yamamoto S (2004) Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 47:2047–2053CrossRefPubMed

Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284–291CrossRefPubMed

Madoff R (2006) Extended resections for advanced rectal cancer. Br J Surg 93:1311–1312CrossRefPubMed

Austin KK, Solomon MJ (2009) Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum 52:1223–1233CrossRefPubMed

Moore H, Harrison L, Guillem J (2005) Cancer of the rectum: follow-up and management of local recurrence. In: Fazio VW, Church JM, Delaney CP (eds) Current therapy in colon and rectal surgery, 2nd ed edn. Elsevier Mosby, Philadelphia, pp 185–190CrossRef

Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York, pp 143–164

10.

Bhangu A, Ali SM, Cunningham D, Brown G, Tekkis P (2013) Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis 15:156–163CrossRefPubMed

11.

Kim MS, Choi C, Yoo S et al (2008) Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol 38:695–700CrossRefPubMed

12.

Mirnezami AH, Sagar PM, Kavanagh D, Witherspoon P, Lee P, Winter D (2010) Clinical algorithms for the surgical management of locally recurrent rectal cancer. Dis Colon Rectum 53:1248–1257CrossRefPubMed

13.

Selvaggi F, Cuocolo A, Sciaudone G, Maurea S, Giuliani A, Mainolfi C (2003) FGD–PET in the follow-up of recurrent colorectal cancer. Colorectal Dis 5:496–500CrossRefPubMed

14.

Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE (2002) Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 62:207–213CrossRefPubMed

15.

Suzuki K, Dozois RR, Devine RM et al (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39:730–736CrossRefPubMed

16.

Wiig JN, Larsen SG, Dueland S, Giercksky KE (2008) Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence. Colorectal Dis 10:48–57CrossRefPubMed

17.

Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM (1999) Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 6:171–177CrossRefPubMed

18.

Wiig JN, Wolff PA, Tveit KM, Giercksky KE (1999) Location of pelvic recurrence after ‘curative’ low anterior resection for rectal cancer. Eur J Surg Oncol 25:590–594CrossRefPubMed

19.

Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ (1995) Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 82:1401–1405CrossRefPubMed

20.

Rahbari NN, Ulrich AB, Bruckner T et al (2011) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 253:522–533CrossRefPubMed

21.

Hahnloser D, Nelson H, Gunderson LL et al (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502–508PubMedCentralPubMed

22.

Pacelli F, Tortorelli AP, Rosa F et al (2010) Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 17:152–162CrossRefPubMed

23.

Rödel C, Grabenbauer GG, Matzel KE et al (2000) Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 43:312–319CrossRefPubMed

24.

Koom WS, Choi Y, Shim SJ et al (2012) Reirradiation to the pelvis for recurrent rectal cancer. J Surg Oncol 105:637–642CrossRefPubMed

25.

Gagliardi G, Pucciarelli S, Asteria CR et al (2010) A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol 14:229–235CrossRefPubMed

26.

Yu SK, Bhangu A, Tait DM, Tekkis P, Wotherspoon A, Brown G (2013) Chemoradiotherapy response in recurrent rectal cancer. Cancer Med 3:111–117CrossRefPubMedCentralPubMed

27.

Harji DP, Griffiths B, McArthur DR, Sagar PM (2013) Surgery for recurrent rectal cancer: higher and wider? Colorectal Dis 15:139–145CrossRefPubMed

28.

Yamada K, Ishizawa T, Niwa K, Chuman Y, Aikou T (2002) Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 45:1078–1084CrossRefPubMed

29.

Wells BJ, Stotland P, Ko MA et al (2007) Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 14:390–395CrossRefPubMed

30.

Asoglu O, Karanlik H, Muslumanoglu M et al (2007) Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 33:1199–1206CrossRefPubMed

31.

Harji DP, Griffiths B, McArthur DR, Sagar PM (2012) Current UK management of locally recurrent rectal cancer. Colorectal Dis 14:1479–1482CrossRefPubMed

32.

Suzuki K, Gunderson LL, Devine RM et al (1995) Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 75:939–952CrossRefPubMed

33.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedCentralPubMed

34.

Beyond TME Collaborative (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 100:E1–E33CrossRef

35.

Hartley JE, Lopez RA, Paty PB, Wong WD, Cohen AM, Guillem JG (2003) Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified? Ann Surg Oncol 10:227–233CrossRefPubMed

Title: Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients
Authors: F. Selvaggi
C. Fucini
G. Pellino
G. Sciaudone
I. Maretto
I. Mondi
N. Bartolini
F. Caminati
S. Pucciarelli
Publication date: 01-03-2015
Publisher: Springer Milan
Published in: Techniques in Coloproctology / Issue 3/2015
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI: https://doi.org/10.1007/s10151-014-1241-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Repair of complex parastomal hernias

European consensus meeting of ARM-Net members concerning diagnosis and early management of newborns with anorectal malformations

Extralevator versus standard abdominoperineal excision for rectal cancer

Invited comment on van der Steeg et al.: European consensus meeting of ARM-Net members concerning diagnosis and early management of newborns with anorectal malformations

Colonic transit in the empty colon after defunctioning ileostomy: Do we really know what happens?

Re: Staying on Target—reply to comments by Loyal et al.